Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
复制标题
DOI:
10.4049/jimmunol.1601775
复制
发表时间:
2017-07-01
期刊:
影响因子:
--
通讯作者:
Boyaka PN
中科院分区:
文献类型:
--
作者:
Boyaka PN
Mucosal IgA or secretory IgA (SIgA) are structurally equipped to resist chemical degradation in the harsh environment of mucosal surfaces and the enzymes of host or microbial origin. Production of SIgA is finely regulated and distinct T-independent and T-dependent mechanisms orchestrate immunoglobulin heavy chain α class switching and SIgA responses against commensal and pathogenic microbes. Most infectious pathogens enter the host via mucosal surfaces. To provide a first line of protection at these entry ports, vaccines are being developed to induce pathogen-specific SIgA in addition to systemic immunity achieved by injected vaccines. Mucosal or epicutaneous delivery of vaccines helps target the inductive sites for IgA responses. The efficacy of such vaccines relies on the identification/engineering of vaccine adjuvants capable of supporting the development of SIgA alongside systemic immunity and delivery systems that improve vaccine delivery to the targeted anatomic sites and immune cells.
登录
查看更多内容
影响因子:
32.4
作者:
Bunker JJ;Flynn TM;Koval JC;Shaw DG;Meisel M;McDonald BD;Ishizuka IE;Dent AL;Wilson PC;Jabri B;Antonopoulos DA;Bendelac A
通讯作者:
Bendelac A
影响因子:
4.4
作者:
Boullier, Severine;Tanguy, Myriam;Phalipon, Armelle
通讯作者:
Phalipon, Armelle
DOI:
10.4049/jimmunol.0803740
发表时间:
2009-12-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Cuburu N;Kweon MN;Hervouet C;Cha HR;Pang YY;Holmgren J;Stadler K;Schiller JT;Anjuère F;Czerkinsky C
通讯作者:
Czerkinsky C
影响因子:
10.8
作者:
Davitt, Christopher J. H.;McNeela, Edel A.;Lavelle, Ed C.
通讯作者:
Lavelle, Ed C.
影响因子:
32.4
作者:
Chu, Van Trung;Beller, Alexander;Berek, Claudia
通讯作者:
Berek, Claudia